Journal of Contemporary Brachytherapy

Papers
(The TQCC of Journal of Contemporary Brachytherapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Sensitivity of contributing factors to heterogeneity corrections in dosimetry of ocular brachytherapy using iodine-125 COMS plaques14
Urinary tract symptoms that should be improved to enhance post-operative urinary quality of life in patients treated with low-dose-rate brachytherapy for prostate cancer: An importance–performance ana12
Dosimetric impact of applying a model-based dose calculation algorithm for skin cancer brachytherapy (interventional radiotherapy)10
3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results10
Evaluation of risk factors for difficult-to-control pain (VAS score > 3) at two months after late-stage non-small cell lung cancer treatment with iodine-125 radioactive particle implantation combin10
The application of 3D brachytherapy in cervical stump cancer: A retrospective study9
Skin marker for MR-only surface high-dose-rate brachytherapy9
Three-year outcomes of uveal melanoma treated with intra-operative ultrasound-guided iodine-125 brachytherapy using custom-built eye plaques8
Variations and effects of bladder and rectal volume following uniform preparation procedure in cervical cancer: Five fractions of 6 Gy8
Clinical implementation of three-dimensional standardized template-guided brachytherapy for patients with locally advanced cervical cancer7
Clinical and dosimetric outcomes of carcinoma cervix patients treated with MRI only at first fraction, followed by CT-based image-guided brachytherapy for subsequent fractions7
Technical details and clinical outcomes after high-dose-rate intracavitary brachytherapy for squamous cell carcinoma of external auditory canal and external beam radiotherapy for nodal coverage: A c7
Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity6
Pain and symptom relief using inhaled methoxyflurane for gynecologic brachytherapy applicator removal6
Why is a very easy, useful, old technique underused? An overview of esophageal brachytherapy – interventional radiotherapy6
Dosimetric comparison of AcurosTM BV and AAPM TG-43 formalism for interstitial iridium-192 high-dose-rate brachytherapy6
Interstitial brachytherapy for internal mammary node in breast cancer: A case report6
Hydrogel spacer injection to the meso-sigmoid to protect the sigmoid colon in cervical cancer brachytherapy: A technical report6
A retrospective study on unresectable or inoperable head and neck cancers treated with stereotactic ablative brachytherapy6
Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer6
Clinical implementation of failure modes and effects analysis for gynecological high-dose-rate brachytherapy6
Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions6
Are active dwell positions always necessary in the ring/ovoids channel of the cervical applicator in the intracavitary-interstitial brachytherapy of cervical cancer?5
Auxetic solution for enhanced esophageal brachytherapy applicator5
Is perioperative brachytherapy effective in carcinoma of the tongue?5
Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse5
Comparison of vaginal gauze packing technique with or without balloon in high-dose-rate brachytherapy of uterine cervical cancer: a crossover randomized controlled trial5
Salvage percutaneous high-dose-rate brachyablation after stereotactic body radiation therapy for early-stage non-small cell lung cancer5
Freiburg flap used as vaginal applicator with/without free-hand interstitial needles in three-dimensional high-dose-rate brachytherapy for vaginal stump recurrence of cervical cancer5
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer5
Development of GUI-based simple independent dose calculation software without DICOM data transfer for high-dose-rate brachytherapy4
Deep learning-based auto-segmentation model for clinical target volume delineation in brachytherapy after parotid cancer surgery4
Intensity-modulated vaginal brachytherapy applicator and single- and multi-channel applicators in vaginal cuff brachytherapy4
Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination4
Comparison of dosimetric analysis of organs at risk and target volumes for ovoids and cylinders in endometrial carcinoma4
Advanced non-melanoma skin cancer in elderly patients: When surgery says NO, interventional radiotherapy (brachytherapy) says YES4
Validation of the bladder neck as an important organ at risk in prostate seed brachytherapy based on D2cc: A single-institution, retrospective review4
Letter to the Editor-in-Chief regarding “Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients”4
Automatic contouring using deformable image registration for tandem-ring or tandem-ovoid brachytherapy4
Comprehensive analysis of dosimetry correlation and clinical outcomes in image-guided brachytherapy vs. intensity-modulated radiotherapy photon boost after whole breast hypofractionated radiation in p4
Injectable bio-absorbable spacers in brachytherapy for gynecological cancers: A scoping review4
Augmented reality in brachytherapy: A narrative review4
Combined CT-guided high-dose-rate brachytherapy (CT-HDRBT) and transarterial chemoembolization with irinotecan-loaded microspheres improve local tumor control and progression-free survival in patients3
Investigation of in vivo source tracking error thresholds for interstitial and intra-cavitary high-dose-rate cervical brachytherapy3
Inter-observer variation of target volume delineation for CT-guided cervical cancer brachytherapy3
Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series3
Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results3
Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?3
X-ray spectra emitted by the electronic brachytherapy unit Papillon 50 measured with a CdTe spectrometer3
Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario3
Safety and efficacy of iridium-192 high-dose-rate interstitial brachytherapy for pleural and chest wall tumours: preliminary results3
Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy3
Brachytherapy dose changes: comparing in-room and out-room image-guided brachytherapy. A randomized study3
Dosimetric comparison of two afterloaders and treatment planning systems in vaginal high-dose-rate brachytherapy3
Effect of applicator removal from target volume for cervical cancer patients treated with Venezia high-dose-rate brachytherapy applicator3
Differential outcomes of re-stratified high-risk prostate cancer patients treated with external beam radiation therapy plus high-dose-rate brachytherapy boost3
Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule3
Feasibility and efficacy of endoscopic ultrasound-guided iodine-125 seed implantation in inoperable ampullary carcinoma: initial clinical experience3
Efficacy of medial needles in mitigating dose deficits from sub-optimally inserted tandems in cervical interstitial brachytherapy3
0.099104166030884